Treatment for SMA

There are currently two treatments for SMA, however, just one approved in Europe. This compound is marketed by the pharmaceutical company Biogen under the trade name of Spinraza.

Spinraza™ was approved for the treatment of SMA in the US in December 2016 by the FDA and in Europe in June 2017 by the European Commission.

 

Info iconMore information